Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Clinical Evaluation of Two Post Systems for Single Crown Restoration of Anterior Teeth

NCT07827755 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-10-02
Last updated
2026-10-20

Condition(s) studied

Cairo UniversityNonvital Tooth

Investigational drug(s) / intervention(s)

Custom-Fit UHMWPE Fiber Post with Composite Core

Custom-Fit UHMWPE Fiber Post with Composite Core: Participants receive a custom-fit UHMWPE fiber post, individually adapted to the canal at chairside, followed by a composite core build-up and definitive crown restoration.

Study summary

This randomized controlled trial evaluates two post systems used to restore endodontically treated (root canal treated) maxillary anterior teeth with 1-2 missing coronal walls. Participants will be randomly assigned to receive either a custom-adapted polyethylene fibers post (Ribbond-type, individually formed) or a prefabricated fiber post, followed by a composite core and crown restoration. The primary outcome is the distance between the post and the remaining root canal filling (gutta-percha), measured radiographically, which reflects how well the post adapts within the canal. The secondary outcome is post and restoration retention, assessed clinically using USPHS criteria. Participants will be followed for 6 months. The study aims to determine whether a custom-fitted fiber post provides better adaptation and retention compared to a standard prefabricated fiber post in teeth with significant structural loss.

Eligibility

Sex
ALL
Min age
20 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * Endodontically treated maxillary anterior teeth (incisors and/or canines) * Presence of 1-2 missing coronal axial walls (mesial, distal, labial, and/or palatal), assessed at the cementoenamel junction (CEJ) * Remaining sound tooth structure meeting minimum ferrule criteria: wall height ≥1.5-2 mm and circumferential thickness ≈1 mm * Adequate root canal filling with no radiographic signs of periapical pathology * Root length and canal morphology suitable for post space preparation * Patients aged 20-40 years * Willing and able to provide informed consent and attend follow-up visits Exclusion Criteria: * Teeth with 3 or more missing coronal axial walls (insufficient ferrule) * Evidence of active periapical pathology, root fracture, or root resorption * Insufficient remaining root length for adequate post retention * Signs of periodontal disease affecting tooth prognosis (e.g., mobility, inadequate periodontal support) * Systemic conditions contraindicating routine dental treatment * Pregnancy (if radiographic follow-up is required) * Inability to attend scheduled follow-up visits

Primary outcome measure(s)

  • Post-Gutta-Percha Gap Distance — Immediately post-cementation (baseline)
    Distance between the outer surface of the cemented post and the residual root canal filling (gutta-percha), measured radiographically at the coronal, middle, and apical thirds of the post space. Reported both as a continuous measurement (mm) and dichotomized as no gap versus any measurable gap.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dentistry Cairo University Cairo Manial

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07827755 on ClinicalTrials.gov ↗ ← All trials in Egypt